Search
Parkinson's Disease Paid Clinical Trials in Nebraska
A listing of 4 Parkinson's Disease clinical trials in Nebraska actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 4 of 4
The state of Nebraska currently has 4 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Omaha, Lincoln, Kearney and Grand Island.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Acid Reflux Esophagus Damage Study
Recruiting
Become part of a clinical trial today and play a role in driving medical research forward, aiding in the discovery of groundbreaking therapies. Get rewarded for your time with monetary compensation and enjoy access to medical treatment at no charge.
Featured Trial
Child/Teen Migraine Study
Recruiting
Sign up for a clinical trial today and contribute to the advancement of medical research, paving the way for innovative treatments. Receive financial compensation for your participation and benefit from complimentary medical care.
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Recruiting
Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease. This study will determine if a lower dose (5 millicuries) would suffice.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/02/2024
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson Disease, Movement Disorders
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
Recruiting
This is an open-label, non-randomized, proof-of-concept comparison of clinical vs. research stimulation patterns in patients with Parkinson's disease (PD) being treated with Deep Brain Stimulation (DBS) through the Medtronic Percept PC DBS device. The investigators hypothesize that stimulation patterns designed to better target excessive synchrony in a patient-tailored manner may result in more efficient and effective therapy with fewer side effects. Medtronic 3rd-generation sensing implantable... Read More
Gender:
All
Ages:
Between 19 years and 80 years
Trial Updated:
01/10/2024
Locations: Unversity of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson's Disease
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
Recruiting
This study is aimed at testing the hypothesis that adaptive stimulation of the Subthalamic Nucleus (STN) drives changes in sleep episode maintenance and improves sleep quality. Investigators will directly test the efficacy of an adaptive stimulation protocol. Study subjects are adults with Parkinson's disease who experience inadequate motor symptom relief, and who have been offered implantation of a deep brain stimulator system targeting STN for the treatment of motor symptoms (standard-of-care)... Read More
Gender:
All
Ages:
Between 19 years and 80 years
Trial Updated:
10/19/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson's Disease, Sleep Fragmentation
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
Recruiting
Investigators will evaluate the safety of a 48 week regimen of Leukine administered as a weight-based dose at 3 ug/kg/ day for 5 days followed by a 2-day holiday. This 48 week long study will extend the prior biomarker evaluations observed in a previous study. Clinical signs and symptoms will be measured by personal well-being, physical, and neurological examinations (UPDRS Parts I, II, III, and IV assessments) and blood tests (CBC with differential, total T cell count, and a comprehensive metab... Read More
Gender:
All
Ages:
Between 35 years and 85 years
Trial Updated:
09/28/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Parkinson's Disease and Parkinsonism
1 - 4 of 4